"Ośrodki Chirurgii Oka Prof. Zagórskiego powstały w celu spełniania misji przywracania lub zachowania widzenia u wszystkich potrzebujących ludzi. Klinika zajmuje się leczeniem schorzeń oczu i zaburzeń widzenia."

During the past decade, Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow" are "Diabetic Macular Edema" (2 trials). Many other conditions were trialed in "Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow" in a lesser frequency.

Most popular intervention types in "Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osrodek Chirurgii Oka prof. Zagorskiego Rzeszow, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".